GlaxoSmithKline provides further update on divestment of non-core over-the-counter (OTC) brands
15 March 2012 | By GlaxoSmithKline
Agreement reached to divest brands in Europe to Omega Pharma for €470m (£391m)...
List view / Grid view
15 March 2012 | By GlaxoSmithKline
Agreement reached to divest brands in Europe to Omega Pharma for €470m (£391m)...
14 March 2012 | By HACH LANGE
Modern pharmaceutical injectable drug production is heavily regulated...
13 March 2012 | By Roche
The 2nd request seeks additional information regarding Roche’s microarray business...
13 March 2012 | By kdm communications limited
Laboratory scale chemists offered educational workshops and seminars...
13 March 2012 | By AstraZeneca
AstraZeneca will vigorously defend its legal rights...
12 March 2012 | By Pfizer
Data from a Phase 3 study of Prevnar 13® met all study endpoints...
12 March 2012 | By Pfizer
Biocon and Pfizer have announced the conclusion of their alliance...
9 March 2012 | By GlaxoSmithKline
New scheme to offer 40 annual apprenticeships in manufacturing, R&D and IT...
9 March 2012 | By AstraZeneca
The FDA denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labelling...
8 March 2012 | By Abbott
U.S. FDA clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System...
7 March 2012 | By Primetek Solutions
The new MiniSeal Plus heat sealer from Porvair Sciences operates with a very high force...
7 March 2012 | By Primetek Solutions
The Ultrajet pipette controller from Porvair Sciences is an easy-to-use electronic pipette filler...
7 March 2012 | By Primetek Solutions
Many scientists around the world have come to rely upon the Porvair Sciences Catalogue as a primary source of information...
7 March 2012 | By Primetek Solutions
Porvair Sciences has introduced a low profile deep well microplate...
7 March 2012 | By Primetek Solutions
Constructed in ultra-pure grade polystyrene, the opaque white Krystal 2000 plate from Porvair Sciences Ltd...